Evidence map›Paper›PMID 27583470›Full record

ArticleThe Journal of clinical endocrinology and metabolism2016

Adrenomedullin2 (ADM2)/Intermedin (IMD): A Potential Role in the Pathophysiology of Preeclampsia.

Madhu Chauhan, Meena Balakrishnan, Alex Vidaeff, Uma Yallampalli, Fernando Lugo, Karin Fox, Michael Belfort, Chandra Yallampalli

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Madhu ChauhanDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Meena BalakrishnanDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Alex VidaeffDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Uma YallampalliDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Fernando LugoDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Karin FoxDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Michael BelfortDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Chandra YallampalliDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Baylor College of Medicine · US

Funding

SEX STEROID HORMONES AND CALCITONIN GENE RELATED PEPTIDER01HL058144 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CHAUHAN, MADHU LATA S., YALLAMPALLI, CHANDRASEKHAR · 1998 to 2022
$6.9M
Intermedin / AM2 in Human PregnancyR03HD054867 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHAUHAN, MADHU LATA S. · 2007 to 2009
$223k
NHLBI NIH HHS R01 HL058144NICHD NIH HHS R03 HD054867
6 · The paper itself

Abstract

contextIt is not known whether decreases in trophoblast invasion promoting the peptide, adrenomedullin2 (ADM2) system is associated with preeclampsia (PreE).

objectiveThe objective of the study was to assess the changes in ADM2 levels in plasma, placenta, and amniotic fluid (AF) and its receptor components in placenta from PreE pregnancy compared with the age-matched normal and study the effect of ADM2 on the synthesis of nitric oxide (NO), endothelial nitric oxide synthase (eNOS), and matrix-metalloproteinase (MMP)-2 and MMP-9 in trophoblast cells.

resultsPreE is associated with a decreased expression of ADM2 in plasma and placenta (P < .05); ADM2 interacts with a seven-transmembrane G protein-coupled receptor, calcitonin receptor-like receptor (CRLR) in HTR-8/SVneo cells; placental expression of ADM2/CRLR complex is lower in PreE; mRNA for CRLR and receptor activity-modifying protein-3 are lower, whereas receptor activity-modifying protein-2 is higher in the PreE placenta (P < .05); ADM2 levels in the second trimester are lower in the AF from pregnant women who develop PreE later in gestation (P < .05); ADM2 is localized to the epithelium of the amnion and the ectoderm and mesoderm of the chorion in term fetal membranes; ADM2 increases NO production, eNOS, and MMP2/9-immunoreactivity, whereas ADM2 knockdown inhibits the expression of eNOS and MMP2/9 mRNA and S-nitrosylation in HTR-8/SVneo cells; and ADM2-induced increases in MMP2/9 activity is inhibited by L-nitro-arginine methyl ester in HTR-8SV/neo cells.

conclusionDecreases in the ADM2 system in PreE at term, in AF from pregnant women during the second trimester who develop PreE later in gestation, and ADM2-induced increases in the NO and MMP-2/9 levels in trophoblast cells suggest a potential role for ADM2 via the NO-MMP system in the pathophysiology of PreE.

Indexed as

AdultAmniotic FluidCells, CulturedFemaleHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9Nitric OxideNitric Oxide Synthase Type IIIPeptide HormonesPlacentaPre-EclampsiaPregnancyPregnancy Trimester, SecondTrophoblastsADM2 protein, humanMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanMMP9 protein, humanNitric OxideNitric Oxide Synthase Type IIIPeptide Hormones

Identifiers

PMID27583470
PMCPMC5095259
OpenAlexW2516792323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.